| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |